A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat
Public ClinicalTrials.gov record NCT04150289. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Disease Registry Encompassing the Care of Patients With Multiple Myeloma on Panobinostat (RECOMM)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study aims to describe current treatment patterns in the real-world setting among patients with multiple myeloma who are initiating treatment with (or changing treatment to) panobinostat and explore the associations with baseline patient characteristics, healthcare resource utilization, and clinical outcomes.
Study identification
- NCT ID
- NCT04150289
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 248 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 3, 2019
- Primary completion
- Mar 29, 2022
- Completion
- Mar 29, 2022
- Last update posted
- Jun 14, 2023
2019 – 2022
United States locations
- U.S. sites
- 7
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| American Health Network Indiana | Indianapolis | Indiana | 46260 | — |
| Southern Nevada Cancer Research Foundation and Optum Cancer Care | Las Vegas | Nevada | 89106 | — |
| Oncology Specialists of Charlotte | Charlotte | North Carolina | 28204 | — |
| Southern Oncology Specialists | Huntersville | North Carolina | 28078 | — |
| Gettysburg Cancer Center | Gettysburg | Pennsylvania | 17325 | — |
| Coastal Cancer Center | Myrtle Beach | South Carolina | 29572 | — |
| Carolina Blood and Cancer Care Associates | Rock Hill | South Carolina | 29732 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04150289, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 14, 2023 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04150289 live on ClinicalTrials.gov.